Our current projects are dedicated to advancing knowledge and innovation in Cancer Biology, Neuroscience, Cardiopulmonary Disorders, and Infectious Diseases. Each project represents our commitment to translating ground-breaking discoveries into tangible solutions that address critical health challenges. Dive into our active research efforts to see how we’re pushing the boundaries of science and improving patient outcomes.
Cancer Biology & Clinical Oncology
Our research in cancer biology and clinical oncology is focused on unravelling the complexities of cancer to improve patient outcomes. Our active projects include:
- Molecular Mechanisms of Tumor Progression: We investigate the genetic and molecular pathways driving cancer development and metastasis. Learn more about our work in this area.
- Cancer Biomarkers and Early Detection: Our team identifies and validates biomarkers crucial for the early diagnosis and prognosis of various cancers. Explore our current biomarker research.
- Novel Therapeutics and Drug Resistance: We are developing and testing innovative therapies, including targeted treatments and immunotherapies, to overcome drug resistance. Discover our latest therapeutic advancements.
- Translational Research: Bridging laboratory discoveries with clinical applications, we translate basic research findings into actionable treatments for patients. See how we’re advancing translational research.
Neuroscience
In the realm of neuroscience, our focus is on understanding the brain and nervous system to address various disorders. Our current projects include:
- Stress and Related Disorders: We explore the neural circuits involved in stress and related disorders, aiming to understand and mitigate conditions like depression. Read about our stress research.
- Neurobiology of Glial Cells: Our research delves into the role of glial cells in brain function and their impact on neurological health. Learn more about our glial cell studies.
- Pathophysiology of Neuronal Disorders: We investigate neural circuit dysfunctions and cellular factors contributing to disorders such as stroke and traumatic brain injury. Explore our research on neuronal disorders.
- Neurodegenerative Disorders: Our work focuses on the mechanisms underlying neurodegenerative diseases like Alzheimer’s and Parkinson’s, with the goal of developing new therapeutic strategies .Find out more about our neurodegenerative research.
Cardiopulmonary Disorders
Our research in cardiopulmonary disorders aims to enhance the understanding and treatment of heart and lung diseases. Active projects include:
- Biomarkers for Early Diagnosis and Prognosis: We are identifying biomarkers for early detection and prognosis of cardiac conditions such as heart failure and cardiomyopathies. See our latest findings on cardiac biomarkers.
- Mechanisms of Pulmonary Disorders: Our research investigates the biological mechanisms underlying pulmonary diseases like COPD and pulmonary hypertension. Learn more about our pulmonary disorder studies.
- Therapeutic Strategies for Cardiopulmonary Disorders: We are developing and evaluating novel therapeutic approaches for cardiopulmonary conditions, including drug targets and combination therapies. Discover our therapeutic strategies.
Infectious Diseases, Microbiology & One Health
Our research in this domain focuses on understanding and combating infectious diseases through a One Health perspective. Current projects include:
- Immune System Responses to Infections: We study how the immune system responds to infections and the role of immune dysregulation in disease. Explore our research on immune responses.
- Microbial Infection, Resistance, One Health and Epidemiology: Our work covers the interactions between microbes, their environments, and human health, including epidemiological studies on infection spread and control. Learn more about our microbial research.
- Therapeutic Strategies for Infectious Diseases: We develop and assess strategies to prevent and treat infections, focusing on new antiviral, antibacterial, and antifungal agents. See our latest therapeutic developments.